Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | ACE | P12821 | 9/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21462327 | 0.90 | OPRD1 (0.49) | KMT2AF2ACEACE2DPP4 | |
| SCHEMBL31258873 | 0.90 | OPRD1 (0.49) | KMT2AF2ACEACE2DPP4 | |
| SCHEMBL29444020 | 0.90 | OPRD1 (0.49) | KMT2AF2ACEACE2DPP4 | |
| SCHEMBL30034009 | 0.87 | OPRD1 (0.47) | KMT2AF2ACEACE2OPRD1 | |
| SCHEMBL28665306 | 0.87 | OPRD1 (0.48) | KMT2AF2ACEACE2OPRD1 | |
| SCHEMBL30366864 | 0.87 | OPRD1 (0.48) | KMT2AF2ACEACE2OPRD1 | |
| SCHEMBL31603928 | 0.85 | KMT2A (0.46) | KMT2AF2ACEDPP4OPRD1 | |
| SCHEMBL31603930 | 0.83 | F2 (0.46) | KMT2AF2ACEDPP4 | |
| SCHEMBL119560 | 0.82 | ALDH1A1 (0.58) | KMT2AF2ACEALDH1A1SMN1; SMN2 | |
| SCHEMBL1002927 | 0.82 | ALDH1A1 (0.58) | KMT2AF2ACEALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120058841-A | Synthesis method of snake venom tetrapeptide | 上海鲲诺生物科技有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-115327010-B | Fmoc-L-Pro-OH.H 2 Method for measuring content of O and related impurities | 泰州兴普泰生物制药有限公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-115327010-A | Fmoc-L-Pro-OH.H 2 Method for measuring content of O and related impurities | 泰州兴普泰生物制药有限公司 | 2022-11-11 | — | — | CN | disclosed |
| CN-114380887-A | Liquid phase fragment synthesis method of snake venom-like tripeptide | 深圳翰宇药业股份有限公司 | 2022-04-22 | — | — | CN | disclosed |